Idorsia (United Kingdom)

Idorsia

How to Contact Idorsia

About Idorsia

Idorsia UK represents the British operations of the Swiss biopharmaceutical company developing innovative medicines for unmet medical needs in sleep medicine, cardiovascular disease, and rare diseases. The company’s portfolio includes QUVIVIQ (daridorexant), a dual orexin receptor antagonist for the treatment of chronic insomnia in adults.

Medications

Medications Manufactured by Idorsia

Experienced a Side Effect?

Report to

👉
Yellowcard logo
(UK)
👉
Medwatch logo
(US)
Now Patient SideEffects